Treatment of Wilson's disease with zinc (Q78245714)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482318%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

review article

1 reference

title

Treatment of Wilson's disease with zinc (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482318%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

G J Brewer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482318%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482318%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482318%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482318%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482318%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

322-324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482318%20AND%20SRC:MED&resulttype=core&format=json

Zinc treatment of Wilson's disease

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Treatment of Wilson's disease with zinc: XV long-term follow-up studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Oral zinc therapy for Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Oral zinc in Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Hypocupremia Induced by Zinc Therapy in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Treatment of Wilson's disease with zinc XII: dose regimen requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

The treatment of Wilson's disease with zinc. IV. Efficacy monitoring using urine and plasma copper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Treatment of Wilson's disease with zinc: XIV. Studies of the effect of zinc on lymphocyte function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Treatment of Wilson's disease with zinc: XI. Interaction with other anticopper agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Metallothionein and its relationship to the metabolism of dietary zinc in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Intestinal metallothionein and the mutual antagonism between copper and zinc in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Initial therapy of patients with Wilson's disease with tetrathiomolybdate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990213-5

10.1016/S0022-2143(99)90213-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482318%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference